MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Gingrich’s health consulting group goes under | Wall Street Beat

Gingrich’s health consulting group goes under | Wall Street Beat

By

MassDevice.com Wall Street Beat

The Center for Health Transformation, a health care think tank launched by GOP presidential hopeful Newt Gingrich, filed for Chapter 7 bankruptcy this week, listing liabilities of between $1 million and $10 million that it says it can’t repay.

The organization’s assets, which it listed in court filings at between $50,000 and $100,000, will be liquidated and the business may subsequently close.

Speculators say the organization’s downfall may mean the end of the former House Speaker’s already struggling bid for the White House. Gingrich hasn’t won a primary since taking his home state of Georgia early last month.

Gingrich said last week that he plans tocut ⅓ of his campaign staff and significantly scale back his campaigning, The Hill reported.

"This ends his campaign. He’ll now be completely on the defensive about this," Emory University political science professor Merle Black told the Atlanta Business Journal.

Gingrich stepped down from a leadership role within the Atlanta, Ga.-based group, also known as The Gingrich Group LLC, when he launched his 2012 presidential campaign.

 Device makers race to all-in-one diabetes care
Medical device makers, including Medtronic (NYSE:MDT), Insulet (NSDQ:PODD), PositiveID (OTC:PSID) and a clutch of private players, are vying to be the 1st to bring an all-in-one diabetes care device to the U.S. market.

Such a device would incorporate a glucose meter, testing strips, insulin pumps and new products such as biosensors and wireless data transmitters into a single product to serve the estimated 25.8 million Americans with diabetes. Read more

 Device tax is no big deal, say med-tech execs
A panel of medical device executives dismissed the impending medical device tax as "not really a concern" at the Bay Area Biomedical Device Conference last week.  

"I would rather see more-rationalized decision making at the FDA level than worry about the tax," Penumbra CEO Adam Elsesser said. Read more

 Bioject’s independent accountant resigns amid uncertainty

Bioject Medical Technologies received the resignation of its independent registered accounting firm, Moss Adams LLP, following the modification of the device maker’s financial statements for the last 2 years to account for uncertainty about Bioject’s "ability to continue as a going concern." Read more

 Gabelli puts some skin in Zoll
Über-investor Mario Gabelli bought of 2.6% Zoll Medical (NSDQ:ZOLL), which recently received a $2.21 billion cash offer from Asahi Kasei Corp. (TYO:3407). Read more

 Hologic lands DoD contract worth up to $98 million

The U.S. Defense Dept. issued a modification on the 3rd option year of a contract with Hologic (NSDQ:HOLX), awarding a price adjustment contract with a maximum value of $97.9 million for radiology systems.  Read more

 Angiotech sells Quill tech to Johnson & Johnson
Angiotech Pharmaceuticals Inc.’s (NSDQ:ANPI) sold some of its Quill wound closure intellectual property portfolio to Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon Inc. which will pay an up-front payment of $20 million and up to $42 million more upon certain product development milestones.

In addition, the companies signed a manufacturing and supply agreement through which Angiotech will exclusively manufacture knotless wound closure products utilizing Quill technology for Ethicon. Read more

 MiMedx beats sales goals for Q1
MiMedx Group (OTC:MDXG) beat is own revenue projections for Q1 2012, posting $3.6 million sales and maintaining a $23 million revenue goal for the year. Read more

 EnteroMedics signs exclusive distribution with Bader Sultan & Bros.

EnteroMedics closed a distribution deal making Bader Sultan & Brothers Co. an exclusive distributor for the Maestro rechargeable system, used in bariatric surgery, in Saudi Arabia, Kuwait, Bahrain, Qatar, United Arab Emirates, Oman, Yemen, Iraq and Lebanon. Read more

 Merck buys into VirtualScopics to the tune of up to $9 million

VirtualScopics inked a deal to sell Merck Global Health Innovation Fund up to 3,000 shares of series C preferred stock and potentially more than 2.7 million shares of common stock in a deal worth up to $9 million. Read more

 MTBC acquires GlobalNet
MTBC acquired GlobalNet Solutions, merging the companies’ electronic health record management services in what is becoming a larger trend toward consolidation in the EHR administration services industry. Read more

 GE completes SeqWright acquisition

GE Healthcare (NYSE:GE) completed its acquisition of genomic services provider SeqWright Inc. The terms of the deal were not made public. Read more

 Elron subsidiaries near close on merger
Elron Electronic Industries (TASE:ELRN) subsidiary Rafael Development Corp. is close to completion on a deal to absorb its subsidiary Starling Advanced Communications, having met all conditions except for a merger certificate issued by the Israeli Registrar of Companies.  Read more

 American CryoStem and Protein Genomics join forces for wound healing
American CryoStem Corp. (OTC:CRYO) and Protein Genomics inked a collaborative agreement to jointly develop cellular therapies for the wound healing and regenerative markets.  Read more

 Hypertension Diagnostics gets building code violation
HyperTension Diagnostics subsidiary HDI Plastics received a notice of violation for its processing facility in Austin, Texas, for alleged failure to obtain required permits and certificates of occupancy.  Read more

 Abbott hits 52-week high
Abbott (NYSE:ABT) notched a new 52-week high of $61.46 on Wednesday, April 4, amid a flurry of trading.

 Kensey Nash notches yearlong high
Kensey Nash (NSDQ:KNSY) set a new 52-week high this week, closing at $29.60 on Monday, April 2, following a settlement with St. Jude Medical (NYSE:STJ) on a dispute over licenses for the Angio-Seal vascular closure device.

 GPOs: Premier inks deal with Cooper-Atkins
Middlefield, Conn.-based Cooper-Atkins Corp. inked a deal to provide wireless refrigerator temperature monitoring systems to with Premier health care alliance members, effective Feb. 15, 2012.  Read more

 Funding Roundup

 Analysts’ ups and downs

  • St. Jude Medical (NYSE:STJ): Morgan Stanley maintains "equal weight," sees no new problems for Durata lead.
  • Medtronic (NYSE:MDT): Bank of America maintains "buy," raises price target from $42 to $45.
  • Hologic (NSDQ:HOLX): Bank of American and Merrill Lynch initiate with "buy" rating on new products and expectations of double-digit earnings growth.
  • Biomet: Standard & Poor’s maintains B+ and "stable" rating, seeing no effect from deal for DePuy Orthopaedics’ trauma unit.
  • Abbott (NYSE:ABT): Bank of America raises price target from $57 to $65.

In case you missed it

RSS From Medical Design & Outsourcing

  • CVRx CEO Nadim Yared suggests steps toward improving diversity and equality
    In this week’s episode of DeviceTalks Weekly, we follow up with last week’s guest, Nadim Yared, CEO of CVRx, to catch up on how the medtech executive is managing during the pandemic. Yared also shares some far-reaching views on what the medtech industry needs to work toward to improve diversity in its workforce and provide… […]
  • Ogura Industrial touts holding brakes for robotic and medical equipment
    As automation continues to accelerate, there’s a growing need to hold equipment in place in the case of a power failure — or to provide positioning, according to Ogura Industrial, maker of six different styles of holding brakes. With roughly 120 standard models, key features of Ogura Industrial’s holding brake families include brake diameters down… […]
  • What kinds of COVID-19 tests are out there?
    Months into the pandemic, the FDA continues to grant emergency use approval (EUA) to new tests to detect the virus that causes COVID-19 and the antibodies that indicate a person has had it. To date, the FDA has granted EUAs for 171 tests —142 molecular tests, 27 antibody tests, and 2 antigen tests. Given the ever-changing… […]
  • FDA plans to resume onsite inspections later this month
    FDA has a goal of restarting on-site inspections during the week of July 20 — four months after it temporarily halted them — though there will be changes due to the COVID-19 pandemic. The agency today said that it will pre-announce inspections to FDA-regulated businesses. Said FDA: “This will help assure the safety of the… […]
  • Formlabs announces new biocompatible, medical-grade resins
    Formlabs, the Somerville, Mass.–based maker of 3D printers, recently announced six new materials across its Form 3, Form 3B, and Form 2 SLA 3D printers — including two new biocompatible, medical-grade resins. The new material families and resins are meant to provide more options for designers and engineers in fields including: Healthcare — with a… […]
  • Magnolia Medical launches Steripath Gen2 with integrated syringe
    Magnolia Medical this week said it launched its Steripath Gen2 Initial Specimen Diversion Device with an integrated syringe. The device is designed for reducing blood culture contamination in “hard stick” patients and syringe collection protocols. Steripath Gen2 features an integrated syringe that addresses difficult intravenous access. It offers precise control to carefully collect blood samples.… […]
  • How Frankenstein sparked Earl Bakken’s love of medical devices
    When the late Medtronic founder Earl Bakken first watched the classic horror movie “Frankenstein” in the 1930s, it did more than just scare: It inspired. “What intrigued me the most as I sat through the movie again and again, was the creative spark of Dr. Frankenstein’s electricity,” Bakken said in his 1990 autobiography “One Man’s… […]
  • Boston researchers have created a potential N95 mask alternative
    Brigham & Women’s Hospital says it is developing a new, sustainable alternative to N95 respirator masks that are in demand during the COVID-19 pandemic. A team of bioengineers and clinical experts at the Boston-based hospital and the Massachusetts Institute of Technology (MIT) are working on the “injection molded autoclavable, scalable, conformable” iMASC system for providing… […]
  • MIT researchers think they’ve found a way to get more particles through a syringe
    Researchers at the Massachusetts Institute of Technology (MIT) are touting a computational model that could prevent microparticle clogging during injections. Microparticles, which are about the size of a grain of sand, can be difficult to inject if they get clogged in a typical syringe. The research team at MIT developed this new model that determines… […]
  • Fotofab adds direct-imaging machine for chemical etching
    Fotofab announced this week that it has acquired a new Chime Ball Technologies direct-imaging (DI) machine from Technica, USA to optimize its chemical etching process and provide a more advanced level of precision and speed for thin metal parts. The DI machine has CBT’s patented finger-print technology with LED lighting that enables Fotofab to directly… […]
  • Could this heated air filter help fight COVID-19?
    University of Houston researchers and medical real estate development firm Medistar claim that they’ve designed an air filter that can catch and instantly kill the virus that causes COVID-19. Galveston National Laboratory tests on the filter found it killed 99.8% of SARS-CoV-2 virus in a single pass — as well as 99.9% of anthrax spores,… […]

Leave a Reply

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube